Berberich, A., Hielscher, T., Menn, O. J., Wiestler, B., Winkler, F., Platten, M., . . . Wick, A. (2016). Impact of tapering and discontinuation of bevacizumab in patients with progressive glioblastoma. Journal of neuro-oncology, 129(3), . https://doi.org/10.1007/s11060-016-2206-x
Chicago-Zitierstil (17. Ausg.)Berberich, Anne, Thomas Hielscher, Oliver Josef Menn, Benedikt Wiestler, Frank Winkler, Michael Platten, Wolfgang Wick, und Antje Wick. "Impact of Tapering and Discontinuation of Bevacizumab in Patients with Progressive Glioblastoma." Journal of Neuro-oncology 129, no. 3 (2016). https://doi.org/10.1007/s11060-016-2206-x.
MLA-Zitierstil (9. Ausg.)Berberich, Anne, et al. "Impact of Tapering and Discontinuation of Bevacizumab in Patients with Progressive Glioblastoma." Journal of Neuro-oncology, vol. 129, no. 3, 2016, https://doi.org/10.1007/s11060-016-2206-x.